China, India drugmakers must be cutting corners, says Teva Europe CEO; FDA finds fake Tamiflu via the Internet;

> Teva Europe's CEO Gerald Van Odijk says he wants regulators to conduct dawn raids on pharma plants in India and China because price analyses show that drugmakers there must be cutting corners. Article

> The FDA is warning consumers about Generic Tamiflu, sold over the Internet, which contains none of the real McCoy's active ingredient but instead a penicillin-like antibiotic. Article

> Swiss-based API maker Siegfried USA broke ground last week for a $1.5 million, 7,000-square-foot warehouse at its manufacturing plant in Pennsville Township, NJ. Article

> VeriPac 455 is a non-destructive inspection system for micro leak detection of empty and pre-filled syringes. Item

> TCP Reliable has set up a business unit to provide regulatory and cold chain compliance products to the US market. Release

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.